China Daily

Larger role seen for traditiona­l medicines

- By WANG XIAOYU wangxiaoyu@chinadaily.com.cn

Chinese and foreign politician­s and health experts called on Tuesday for concerted efforts to study the clinical outcomes of the use of traditiona­l medicines against the novel coronaviru­s to enable traditiona­l therapies to play a larger role in the battle against the COVID19 pandemic.

The joint initiative also stressed offering more support to individual­s and social organizati­ons specializi­ng in traditiona­l medicines and striving to integrate them with regular healthcare services and community-level virus control efforts.

It was announced by Yu Wenming, head of the National Administra­tion of Traditiona­l Chinese Medicine, at a forum held in Beijing.

Foreign dignitarie­s and officials from 28 countries and regions, as well as experts from the World Health Organizati­on, attended the event via video link.

“We support using traditiona­l medicines — with traditiona­l Chinese medicine as a representa­tive — to prevent and control the pandemic and safeguard the health of people,” Yu said.

“An open and inclusive mindset is needed now more than ever.”

Zhang Boli, president of Tianjin University of Traditiona­l Chinese Medicine, said TCM had been a vital tool in suppressin­g the domestic outbreak because it prevented mild and moderate cases from worsening into severe infections.

“A serious COVID-19 patient would cost tens of thousands of yuan, while a mild case only costs less than 10,000 yuan ($1,520),” he said.

“TCM’s role in reducing the rates of severe infections is of critical clinical value.”

Huang Luqi, president of the China Academy of Chinese Medical Sciences, said nearly 92 percent of COVID-19 patients in China had undergone TCM treatment, with the overall efficacy exceeding 90 percent.

One of the most popular TCM drugs, Huashi Baidu granules, which stems from a centurieso­ld prescripti­on, was given market approval by the top drug regulator on March 2.

Huang said three large clinical trials conducted in Wuhan, capital of Hubei province — the Chinese city hit hardest by the epidemic last year — had demonstrat­ed the medication’s efficacy in shortening the period it took for severe patients to clear the coronaviru­s, and aiding the recovery of mild and moderate cases.

He added that the drug also amplified the efficacy of Western medicines when they were used in combinatio­n.

China has held more than 110 video conference­s with 150 countries and regions to promote the use of TCM in treating COVID-19 cases and has given TCM products to over 20 countries and regions.

TCM experts have also been dispatched to over 20 countries and regions, while the internatio­nal community is showing willingnes­s to set up new platforms to enhance TCM collaborat­ion and training, Chinese officials said.

Laotian Health Minister Bounkong Syhavong said his country is now paying increasing attention to the antiviral properties of traditiona­l medicines, especially after some herbal medicines helped treat or alleviate COVID-19 symptoms.

He said Laos is looking forward to enhancing collaborat­ion on research into traditiona­l medicines and improving oversight of the sector with other countries.

Newspapers in English

Newspapers from Hong Kong